Medicines

Thirty-fifth meeting of the Expert Committee on Drug Dependence

The Thirty-fifth meeting of the Expert Committee on Drug Dependence was held in Hammamet, Tunisia from Monday 4 - Friday 8 June 2012.

Agenda and Meeting Documents

1. OPENING OF MEETING

Report on the 35th session

2. PROCEDURAL MATTERS

2.1 Election of chairperson, vice-chairperson and rapporteur
2.2 Adoption of agenda
2.3 Introduction to evaluation process

3. FOR INFORMATION
OF THE COMMITTEE

3.1 Revision of Guidelines

3.2 Work of international bodies concerned with controlled substances

4. CRITICAL REVIEW
OF PSYCHOACTIVE SUBSTANCES

4.1 GHB

4.2 Ketamine INN

5. PRE-REVIEW

5.1 Dextromethorphan pINN

5.2 Tapentadol

5.3 Piperazines

N-benzylpiperazine (BZP)

1-(3-trifluoromethanyl-phenyl)piperazine (TFMPP)

1-(3-chlorophenyl)piperazine (mCPP)

1-(4-Methoxyphenyl)piperazine (MeOPP)

1-(3,4-methylenedioxybenzyl)piperazine (MDBP)

5.4 Gamma-butyrolactone

5.5 1,4-Butanediol

6. OTHER ISSUES

6.1 Use of terms

6.2 Use of pharmacovigilance data for the assessment of dependence and abuse potential (procedures and methodology)

6.3 Balancing medical availability and prevention of misuse of medicines manufactured from controlled substances

6.4 Improving the evidence base of substance evaluation

7. FUTURE REVIEWS OF SUBSTANCES AND OTHER TOPICS TO BE DISCUSSED BY THE ECDD

8. ADOPTION OF REPORT

9. CLOSURE OF MEETING

Share